Pyxis Oncology, Inc. (PYXS)
NASDAQ · Healthcare
Pyxis Oncology, Inc. EBITDA 2024–2025
Pyxis Oncology, Inc. annual/quarterly ebitda history and growth rate from 2024 to 2024. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Pyxis Oncology, Inc. ebitda for the quarter ending March 31, 2024 was -4.5 M.
- Pyxis Oncology, Inc. annual ebitda for 2025 was -79.9 M, a 7.60% decrease from 2024.
- Pyxis Oncology, Inc. annual ebitda for 2024 was -86.5 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Pyxis Oncology, Inc. EBITDA — FAQ
Pyxis Oncology, Inc. (PYXS) ebitda over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see PYXS's ebitda history?
The chart and table above show Pyxis Oncology, Inc.'s ebitda by year and by quarter, including the growth rate.